FDA approves Lilly’s EBGLYSS® for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis

The U.S. FDA has approved a new maintenance dosing regimen for Eli…

SciBase Highlights New Research on Nevisense for Detecting Age-Related Skin Barrier Changes

SciBase has unveiled new research demonstrating the potential of its Nevisense platform…

Breakthroughs in Aesthetics & Dermatology | Dr. Khaled Othman: AIDA 2025

Dr. Khaled where top minds in dermatology, aesthetics, and laser medicine are…

From Skin Types to Chronic Conditions: Dr. Jawaher Al Naqbi | AIDA 2025

Dr. Jaher expressed particular excitement about the conference's focus on biologics, JAK…